Details for New Drug Application (NDA): 217676
✉ Email this page to a colleague
The generic ingredient in FLUOROURACIL is fluorouracil. There are fifteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
Summary for 217676
| Tradename: | FLUOROURACIL |
| Applicant: | Alembic |
| Ingredient: | fluorouracil |
| Patents: | 0 |
Pharmacology for NDA: 217676
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 217676
Suppliers and Packaging for NDA: 217676
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 217676 | ANDA | Alembic Pharmaceuticals Limited | 46708-779 | 46708-779-31 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (46708-779-31) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 217676 | ANDA | Alembic Pharmaceuticals Inc. | 62332-779 | 62332-779-31 | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (62332-779-31) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 5GM/100ML (50MG/ML) | ||||
| Approval Date: | Oct 18, 2023 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
